Sort
39,280 grants matching “leukemia”
Mechanisms regulating the aging of HSC niches
$375,750Paul S Frenette · Albert Einstein College Of Medicine · R01 · FY2021 · DK
Mechanisms regulating the aging of HSC niches
$375,750Paul S Frenette · Albert Einstein College Of Medicine · R01 · FY2020 · DK
Mechanisms regulating the aging of HSC niches
$375,750Paul S Frenette · Albert Einstein College Of Medicine, Inc · R01 · FY2018 · DK
Mechanisms regulating the aging of HSC niches
$375,749Paul S Frenette · Albert Einstein College Of Medicine · R01 · FY2019 · DK
Mechanism and therapeutic opportunities of targeting the Tudor domain
$375,715Chun-Wei David Chen · Mayo Clinic Rochester · R01 · FY2025 · CA
Molecular Mechanisms of Impaired DAN Damage Response in Leukemia Pathogenesis
$375,713James J-D Hsieh · Sloan-Kettering Inst Can Research · U01 · FY2011 · CA
Telomere length control by shelterin
$375,687Titia De Lange · Rockefeller University · R01 · FY2011 · CA
Telomere length control by shelterin
$375,687Titia De Lange · Rockefeller University · R01 · FY2012 · CA
Using the Preimplantation Factor (PIF) to Treat Graft-versus-Host Disease
$375,671Asaf Alimardanov · National Center For Advancing Translational Sciences · ZIA · FY2017 · TR
Roles of Lig3 and XRCC1 Genes in Genome Stability
$375,660Alan E Tomkinson · University Of New Mexico Health Scis Ctr · R01 · FY2019 · ES
Cellular and molecular analyses of hematopoietic stem cell [HSC] interactions with bone marrow niches to improve HSC engraftment for transplantation and tolerance induction
$375,617Irving Lerner Weissman · Stanford University · R01 · FY2021 · DK
AKR1C3 Inhibitors as Chemotherapeutic Potentiators
$375,590Paul Trippier · University Of Nebraska Medical Center · R01 · FY2023 · CA
In Silico Screening for Cancer Targets
$375,583Marc Nicklaus · Division Of Basic Sciences - Nci · ZIC · FY2012 · CA
AKR1C3 Inhibitors as Chemotherapeutic Potentiators
$375,548Paul Trippier · University Of Nebraska Medical Center · R01 · FY2022 · CA
Regulation of IL-6-Type Cytokine Cardioprotective Signaling in the Ischemic Heart
$375,500George W. Booz · University Of Mississippi Med Ctr · R01 · FY2010 · HL
PROJECT 3: A High Content Clinical Trial of the MEK inhibitor Trametinib in JMML
$375,487Kevin M Shannon · Indiana University Indianapolis · U54 · FY2023 · CA
PROJECT 3: A High Content Clinical Trial of the MEK inhibitor Trametinib in JMML
$375,486Kevin M Shannon · Indiana University Indianapolis · U54 · FY2022 · CA
Support For Infrastructure of Childhood Leukemia Environmental Research
$375,475Catherine Metayer · University Of California Berkeley · U24 · FY2025 · ES
Revealing the dynamics of RNA metabolism with nucleotide recoding chemistry
$375,463Matthew David Simon · Yale University · R01 · FY2024 · GM
Transcriptional Elongation Control in Development and Disease
$375,458Ali Shilatifard · Northwestern University At Chicago · R01 · FY2016 · CA
Genetic Dissection of Drosophila Hematopoiesis
$375,352University Of California Los Angeles · R01 · FY2003 · HL
Dietary and Lifestyle Determinants of Colon Cancer Recurrence and Survival
$375,317Charles S Fuchs · Dana-Farber Cancer Inst · R01 · FY2010 · CA
Revealing the dynamics of RNA metabolism with nucleotide recoding chemistry
$375,279Matthew David Simon · Yale University · R01 · FY2025 · GM
MLL in Hematopoiesis and Leukemia in the Zebrafish Model
$375,268Carolyn A Felix · Children'S Hosp Of Philadelphia · R01 · FY2013 · CA
Mechanistic biomarkers to enable Bcl2 inhibitor therapies for neuroblastoma
$375,256Michael D Hogarty · Children'S Hosp Of Philadelphia · R01 · FY2024 · CA